If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. One common approach is to try and find a company with returns on ...

A look at the shareholders of Cogstate Limited (ASX:CGS) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a ...

NEW YORK, Sept. 9, 2020 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Cogstate Ltd. (ASX: CGS; OTCQX: COGZF ...

Detailed price information for Cogstate Ltd Ord (COGZF) from The Globe and Mail including charting and trades.

Revenue reached $23.9 million for H1 FY 2025, marking a 19% increase year-over-year and a 3% sequential improvement. Clinical trials revenue grew 5% sequentially and 25% year-over-year, contributing ...

Detailed price information for Cogstate Ltd Ord (COGZF) from The Globe and Mail including charting and trades.

Cogstate shares plunge on revenue and earnings downgrade Immuron shares have the runs after failed US military trial Was Immutep’s share price reaction underdone? CogState (ASX:CGS) shares have ...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'd want to identify a growing return on capital employed (ROCE) and ...

Developed by Cogstate, the CBB is a scientifically validated digital tool that enables cognitive function self-checks and consists of four tests evaluating psychomotor function, attention, learning ...

Cogstate reported strong new sales contracts led by late-stage mood disorder trials, lifting contracted revenue across future years.

Japanese pharma Eisai is boosting its 2019 pact with Australian medtech firm Cogstate and its cognitive function test. The original pact, penned last August, was a development and sales deal centered ...